本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

19.27
+1.558.75%
盤後19.270.00000.00%16:10 EST
成交量:92.07萬
成交額:1,769.20萬
市值:21.39億
市盈率:-12.02
高:19.59
開:18.28
低:18.09
收:17.72
52周最高:44.34
52周最低:15.96
股本:1.11億
流通股本:1.09億
量比:1.34
換手率:0.84%
股息:- -
股息率:- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
淨資產收益率:-22.56%
總資產收益率:-12.16%
市淨率:2.99
市盈率(LYR):-12.02

資料載入中...

2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/19

SEC問詢函

Form CORRESP - Correspondence
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities